QLI - Dhuwit awis perusahaan qlsyy.net

Tandha merek Qilian International Corp (QLI)

Legacy capacity constraints are weighing on the margins of Qilian International (QLI), yet cash flow dynamics on GURU.Markets demonstrate growth, where 0.11 serves as the current value of the indicator. The financial base relies on the production of veterinary antibiotics and licorice extracts. Meanwhile, the company synthesizes these preparations autonomously by purchasing plant components from farmers, which creates a dependency on external raw material suppliers.

QLI - Aset likuid perusahaan Qilian International Holding Group Limited ing rentang 04.07.2022 - 17.08.2024

Rincian metrik komprehensif lan analitis Qilian International Holding (QLI)

Analisis kabeh metrik perusahaan:QLI Qilian International
Sampel barang qlsyy.net

This indicator measures immediate liquidity, reflecting the volume of available funds for operational management and the settlement of liabilities. The dynamics of this metric determine financial stability by excluding market fluctuations in asset values. By analyzing the current cash balance, an investor sees the value of 0.11, which allows for an assessment of the margin of safety. Excess funds reduce profitability, while a deficit creates default risks. For Qilian International (QLI), such reserves are critical amid raw material price volatility in the chemical segment.

Pesaing langsung

Dana dhuwit perusahaan Haleon (HLN)|Volume dana dhuwit perusahaan Kenvue Inc. (KVUE)|Volume dana dhuwit perusahaan VRNA (veronapharma.com)|Sisa dhuwit perusahaan MENS|LGND: Dhuwit awis perusahaan|Sisa dhuwit perusahaan AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Dhuwit awis perusahaan|Alvotech - Sisa dhuwit perusahaan|Dhuwit awis perusahaan LQDA|Galapagos Genomics (GLPG) - Aset likuid perusahaan|Volume dana dhuwit perusahaan ANIP|Dhuwit awis perusahaan Afrezza MNKD|Dana dhuwit perusahaan Amphastar AMPH|Aset likuid perusahaan Pacira BioSciences (PCRX)|ARS Corp - Volume dana dhuwit perusahaan|TBPH: Dana dhuwit perusahaan|AQST: Volume dana dhuwit perusahaan|SCPH - Aset likuid perusahaan|TECX (Tectonic) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tonix Pharmaceuticals Holding Corp. TNXP|Dana dhuwit perusahaan SXT Pharmaceuticals (SXTC)|Volume dana dhuwit perusahaan Eupraxia Pharmaceuticals Inc. (EPRX)|Dana dhuwit perusahaan BioHarvest Sciences BHST|EXOZ (Invizyne) - Total volume dana dhuwit perusahaan|ORMP: Dhuwit awis perusahaan|ENTX (Entera Bio Ltd) - Dhuwit awis lan setara dhuwit awis perusahaan|HYFT: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan QNTM|Volume dana dhuwit perusahaan FGEN|Dhuwit awis perusahaan Telomir Pharmaceuticals TELO|Volume dana dhuwit perusahaan RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Total volume dana dhuwit perusahaan|RLYB - Dana dhuwit perusahaan|LEXX (Lexaria Bioscience Corp.) - Dhuwit awis lan setara dhuwit awis perusahaan|pulmatrix.com (PULM) - Dana dhuwit perusahaan|PTHL (Pheton) - Dana dhuwit perusahaan|Dana dhuwit perusahaan Aptorum|Cadangan dhuwit perusahaan Lyra Therapeutics Inc. LYRA|Volume dana dhuwit perusahaan IBO|TNFA (TNF Pharmaceuticals, Inc.) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan cbdMD, Inc. YCBD|Sisa dhuwit perusahaan PRFX|Altamira Therapeutics Ltd. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Lipella Pharmaceuticals Inc|OPTN: Volume dana dhuwit perusahaan|Pieris - Sisa dhuwit perusahaan|Dhuwit awis perusahaan PROC|Volume dana dhuwit perusahaan petrospharma.com|Volume dana dhuwit perusahaan SLRN|TFFP (TFF Pharmaceuticals Inc.) - Sisa dhuwit perusahaan